Login call us at (412) 357-0632
image

References

  • 1.Cannesson M et al, J Am Coll Cardiol. 2007 Jan 16;49:217-26
  • 2.Pirat B et al, J Am Coll Cardiol, 2008; 51:651-659
  • 3.Masuda K et al, J Am Coll Cardiol, 2008; 1:210-220
  • 4.Nandalur KR et al, J Am Coll Cardiol, 2007; 50:1343-1353
  • 5.Puesken M et al, European Radiology 2008, May 1, published before print
  • 6.Klein C et al, Circulation. 2002;105:162-167, published online before print Jan 15, 2002
  • 7.Shan K et al, Circulation. 2004;109:1328-1334
  • 8.J Am Coll Cardiol Img. 2012;5(8):837-848. doi:10.1016/j.jcmg.2012.06.003
  • 9.Cardiac Tumors in Children: MR Imaging http://www.academia.edu/1740645/Cardiac_Tumors_in_Children_MR_Imaging
  • 10.Anderson C et al, J Am Coll Cardiol Img. 2012;5(8):837-848. doi:10.1016/j.jcmg.2012.06.003
  • 11.Valentina O et al, Circ Res. 2016;119:277-299. doi: 10.1161/CIRCRESAHA.116.307974
  • 12.Madan et al, Pediatr Cardiol. 2013 Jun;34(5):1206-11. doi: 10.1007/s00246-013-0631-6.
  • 13.Assomull RG, Prasad SK, Lyne J, et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 2006;48:1977–85. [CrossRef][Medline][Web of Science]Google Scholar
  • 14.Maceira AM, Joshi J, Prasad SK, et al. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 2005;111:186–93. [Abstract/FREE Full text]
  • 15.O’Hanlon R, Assomull RG, Prasad SK. Use of cardiovascular magnetic resonance for diagnosis and management in hypertrophic cardiomyopathy. Curr Cardiol Rep 2007;9:51–6. [CrossRef][Medline]Google Scholar
  • 16.Smedema JP, Snoep G, van Kroonenburgh MP, et al. The additional value of gadolinium-enhanced MRI to standard assessment for cardiac involvement in patients with pulmonary sarcoidosis. Chest 2005;128:1629–37. [CrossRef][Medline][Web of Science]Google Scholar
  • 17.Rosamond W , Flegal K , Furie K , et al.. Heart disease and stroke statistics: 2008 update—a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008;117:e25–e146
  • 18.W P Bandettini, A E Arai. Advances in clinical applications of cardiovascular magnetic resonance imaging. Heart 2008;94:1485-1495 doi:10.1136/hrt.2007.119016
  • 19.Doyle M, Fuisz A, Kortright E, et al. The impact of myocardial flow reserve on the detection of coronary artery disease by perfusion imaging methods: an NHLBI WISE study. J Cardiovasc Magn Reson 2003;5:475–85.
  • 20.Simonetti OP, Kim RJ, Fieno DS, et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology 2001;218:215–23.
  • 21.Anderson LJ, Holden S, Davis B, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001;22:2171–9.
  • 22.Anderson LJ, Westwood MA, Holden S, et al. Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance. Br J Haematol 2004;127:348–55.
  • 23.Reant P, Lederlin M, Lafitte S, et al. Absolute assessment of aortic valve stenosis by planimetry using cardiovascular magnetic resonance imaging: comparison with transesophageal echocardiography, transthoracic echocardiography, and cardiac catheterisation. Eur J Radiol 2006;59:276–83
  • 24.Srichai MB, Junor C, Rodriguez LL, et al. Clinical, imaging, and pathological characteristics of left ventricular thrombus: a comparison of contrast-enhanced magnetic resonance imaging, transthoracic echocardiography, and transesophageal echocardiography with surgical or pathological validation. Am Heart J 2006;152:75–84.
  • 25.Mohiaddin RH, Kilner PJ, Rees S, et al. Magnetic resonance volume flow and jet velocity mapping in aortic coarctation. J Am Coll Cardiol 1993;22:1515–21. Russo V, Renzulli M, La Palombara C, et al. Congenital diseases of the thoracic aorta. Role of MRI and MRA. Eur Radiol 2006;16:676–84.
  • 26.Steffens JC, Bourne MW, Sakuma H, et al. Quantification of collateral blood flow in coarctation of the aorta by velocity encoded cine magnetic resonance imaging. Circulation 1994;90:937–43.
  • 27.Murray JG, Manisali M, Flamm SD, et al. Intramural hematoma of the thoracic aorta: MR image findings and their prognostic implications. Radiology 1997;204:349–55. [CrossRef][Medline][Web of Science]Google Scholar
  • 28.Cody DD. AAPM/RSNA physics tutorial for residents: topics in CT. Image processing in CT. Radiographics. 22 (5): 1255-68.
  • 29.Perandini S, Faccioli N, Zaccarella A, Re TJ, Mucelli RP. The diagnostic contribution of CT volumetric rendering techniques in routine practice. Indian J Radiol Imaging [serial online] 2010 [cited 2011 Aug 28];20:92-7. Available from: http://www.ijri.org/text.asp?2010/20/2/92/63043
  • 30.Rao ND, Gulati MS, Paul SB et-al. Three-dimensional helical computed tomography cholangiography with minimum intensity projection in gallbladder carcinoma patients with obstructive jaundice: comparison with magnetic resonance cholangiography and percutaneous transhepatic cholangiography. J. Gastroenterol. Hepatol. 2005;20 (2): 304-8.
  • 31.Cody DD. AAPM/RSNA physics tutorial for residents: topics in CT. Image processing in CT. Radiographics. 22 (5): 1255-68.
  • 32.Beth Ripley, Tatiana Kelil, Michael K. Cheezum, Alexandra Goncalves, Marcelo F. Di Carli, Frank J. Rybicki, Mike Steigner, Dimitrios Mitsouras and Ron Blankstein. 3D printing based on cardiac CT assists anatomic visualization prior to transcatheter aortic valve replacement. Journal of Cardiovascular Computed Tomography, 2016-01-01, Volume 10, Issue 1, Pages 28-36
  • 33.Himbert D., and Vahanian A.: Transcatheter aortic valve replacement for patients with heart failure. Heart Fail Clin 2015; 11: pp. 231-242
  • 34.Kasel A.M., Cassese S., Bleiziffer S., et al: Standardized imaging for aortic annular sizing: implications for transcatheter valve selection. JACC Cardiovasc Imaging 2013; 6: pp. 249-262
  • 35.Yang T.-H., Webb J.G., Blanke P., et al: Incidence and severity of paravalvular aortic regurgitation with multidetector computed tomography nominal area oversizing or undersizing after transcatheter heart valve replacement with the sapien 3. JACC Cardiovasc Interv 2015; 8: pp. 462-471